Milestone partnership highlighting Korea's expanding influence in global biotech innovation

MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascul...

June 3, 2025 | Tuesday | News
Taiwan's KMUH inks MoU with AbbVie to accelerate global clinical trials and advance patient-centered innovation

To accelerate clinical trial activation and execution, enhance research quality, and strengthen international competitiv...

June 3, 2025 | Tuesday | News
Australia's PolyActiva secures AUD $40M in Series C to advance ocular drug delivery

Australia-based PolyActiva, a clinical-stage biopharmaceutical company pioneering a novel drug delivery technology to im...

June 3, 2025 | Tuesday | News
Sanofi buys Blueprint Medicines for $9.1 B, expanding portfolio in rare immunological disease

French pharmaceutical company Sanofi and Blueprint Medicines Corporation, a US-based, publicly traded biopharmaceutical ...

June 2, 2025 | Monday | News
“APAC now leads global clinical development of multi-specific antibodies, accounting for over 40% of trials”

What are the major plans in store after this acquisition? Is there a phase-wise plan? Following the acquisition, Syngen...

May 31, 2025 | Saturday | Opinion
Upskilling and flexibility are key to staying relevant as hiring grows

The biopharma job market has been tough, with widespread downsizing and frequent layoffs across big pharma. But the wors...

May 31, 2025 | Saturday | Analysis
APAC's Alliance-Driven Biotech Boom

Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique ge...

May 31, 2025 | Saturday | News
Singapore leads S$10 M national effort to tackle muscle-loss due to ageing

To tackle the growing threat of muscle loss in Singapore’s ageing population, SingHealth Duke-NUS Academic Medical...

May 29, 2025 | Thursday | News
Singapore's EDDC receives US FDA Fast Track Designation for Antibody-Drug Conjugate

The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development,...

May 28, 2025 | Wednesday | News
US FDA-approved Cancer BioShield platform to enter Saudi Arabia and broader Middle East market

ImmunityBio, Inc., a leading immunotherapy company, has announced the signing of a strategic Memorandum of Understanding...

May 28, 2025 | Wednesday | News
Taxis Pharma receives $2.9 M NIH grant to develop therapeutic against antibiotic-resistant Gonorrhea

Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...

May 28, 2025 | Wednesday | News
BioIVT LLC and Handok Biotech sign agreement to advance innovation in South Korea

US-based BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, has a...

May 28, 2025 | Wednesday | News
Singapore, Netherlands forge economic ties in Medtech, Pharma, Biotech, and HeathTech fields

The Singapore Economic Development Board (EDB) and the Brabant Development Agency (BOM) have signed a Memorandum of Unde...

May 20, 2025 | Tuesday | News
Australia develops new blood test to rapidly diagnose rare genetic diseases

Researchers from the University of Melbourne and Murdoch Children's Research Institute (MCRI) in Australia have develope...

May 26, 2025 | Monday | News
AVING News Interview: BioSpectrum Asia's Insights from ICPI Week 2025

It was a privilege to share BioSpectrum Asia’s vision and editorial focus with AVING News during ICPI Week 2025 in...

May 23, 2025 | Friday | Opinion
Alloy Therapeutics enters Japanese market by establishing operations at Shonan Health Innovation Park

Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...

May 23, 2025 | Friday | News
US-Saudi Arabi partnership to advance T regulatory cell therapies for unmet diseases

King Faisal Specialist Hospital & Research Centre (KFSHRC) and Cellenkos Inc., a Texas based clinical stage bio...

May 22, 2025 | Thursday | News
Pfizer enters into exclusive licensing agreement worth $4.8 B with China's 3SBio

Pfizer Inc. has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc., a leading Chinese biop...

May 20, 2025 | Tuesday | News
Japanese startup RevolKa secures $1.4 M funding to advance therapeutic programmes

RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven protein engi...

May 20, 2025 | Tuesday | News
$15 M injection in NTU Singapore to leverage AI in medical education and research

The Sim Foundation has pledged a gift of S$15 million to Nanyang Technological University, Singapore (NTU Singapore), wh...

May 16, 2025 | Friday | News
Collaboration to accelerate genomics innovation in Japan

US-based Illumina, a global leader in DNA sequencing and array-based technologies, and the Okinawa Institute of Science ...

May 16, 2025 | Friday | News
China's Viva Biotech launches new AI-driven drug discovery platform

China-based Viva Biotech recently held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the adv...

May 16, 2025 | Friday | News
US manufactures world's first mRNA-based personalised CRISPR therapy

Aldevron, a global leader in the production of DNA, RNA and protein, together with Integrated DNA Technologies ...

May 16, 2025 | Friday | News
Korean startup Rznomics partners with Eli Lilly to commercialise RNA-editing therapeutics

Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...

May 16, 2025 | Friday | News
Australia announces over $79 M investment towards clinical trials and cohort studies

Administered through the National Health and Medical Research Council’s (NHMRC) Clinical Trials and Cohort St...

May 14, 2025 | Wednesday | News